Search for: "Sanofi US Services Inc" Results 61 - 77 of 77
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Jun 2008, 8:07 am
: (Spicy IP), Latin America: Merck Serono signs distribution agreement with Bristol-Myers Squibb for portfolio of established pharmaceutical brands in Latin America: (IP tango), US: Biotech industry growth to slow due to funding pressures and competition from biosimilars: (Managing Intellectual Property), US: House Commerce Committee posts responses to its questions on biogenerics; not surprisingly, the views run the gamut: (FDA Law Blog), US: Biosimilar debate heats up at… [read post]
13 Jun 2008, 3:40 am
, Schering-Plough Corp – Following dispute over trade dress with Schering-Plough, Fruit of the Earth announces plan to change its package design: (IP Law360), US: Quanta and its impact on biotechnology: (Holman’s Biotech IP Blog), US: BIO files amicus brief asking CAFC to cabin in scope of KSR and hold that its obvious to try dicta does not abrogate the Deuel standard: In re Kubin: (Patently-O), US: StemCells gets patent on enriched central nervous… [read post]
30 May 2008, 9:09 am
: (Spicy IP), India: DCGI preparing document to implement patent-registration linkage: (Spicy IP), New Zealand: Generic pharmaceutical companies taking advantage of NZ IP laws and medicines regulations: (International Law Office), Uganda: Cipla licenses ARV technology into Uganda: (Afro-IP), US: Money saved through generic prescriptions: (GenericsWeb), US: Government plans to keep close tab on drug patent settlements: (GenericsWeb), US: FTC reports 14 deals to delay… [read post]
16 May 2008, 8:03 am
: (GenericsWeb), Europe: New EBA referral T 1319/04 regarding patentability of known medicament for new treatment of same illness: (IPKat), Europe: Patentability of biotechnology in Europe: (IAM), Europe: New EPO Enlarged Board case referrals: T1319/04 Dosage Regimen, T1242/06 Essential Biological Process: (Hal Wegner), Thailand: Compulsory licensing: Affordable health for Thailand thanks to Matrix Labs: (Spicy IP), Thailand: European Parliament set to reprimand Mandelson for… [read post]
9 May 2008, 10:30 pm
: (Ezine @rticles) Global - Patents Rise of machine translation services: (IPKat), USPTO / EPO / JPO progress on ‘common application format’ for expedited examination: (Peter Zura's 271 Patent Blog), Proponents: ‘Time is now’ for TRIPs biodiversity amendment in Doha round: (Intellectual Property Watch), TRIPs amendment in favour of disclosures for genetic resources/traditional knowledge patents gathers support: (Afro-IP), … [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), … [read post]
11 Apr 2008, 9:00 am
’ – 18 – 22 June, US/Alaska: (Public Knowledge), Center for IP 8th Annual IP Symposium – 28-30 May, Maryland US: (Public Knowledge), University of Maastricht: Conference on public health, innovation and intellectual property – 15 April, Maastricht (Netherlands): (IPR-Helpdesk), NLSIU Symposium: ‘Challenges to India’s patent regime’ – 12-13 April: (Spicy IP), Anti-counterfeiting… [read post]
22 Mar 2008, 2:00 am
You might wait 14 more years: (GenericsWeb),US: Hypocrisy at FTCR? [read post]
15 Mar 2008, 7:00 am
India: Gene silencing: (Spicy IP), India: US Patent reform implications for Indian Pharma: (Spicy IP), India: Generic pharmaceutical industry in the spotlight: (International Law Office), India: Supreme Court refuses to stay a Gujarat High Court decision restraining Ranbaxy from airing its controversial ads directed against Paras Pharma's 'Moov' brand: (Spicy IP),India: Patents on ARV drugs could increase costs: (Generic Pharmaceuticals & IP),US: Survey… [read post]
22 Feb 2008, 6:00 pm
Signature Financial Group, Inc., and AT&T Corp. v. [read post]
15 Feb 2008, 9:00 am
: (Spicy IP),USD 20 billion going off-patent: (Patent Circle),Canadian Prices Review Board asserts jurisdiction over products sold in US, but imported into Canada under Special Access Program: (Gowlings),Canadian Court of Appeal affirms decision allowing patent-owner to be joined to proceedings: Cobalt v Pfizer and Pharmascience v Pfizer: (Gowlings),PharmaStem appeals stem cell patent: asks for greater deference to patent examiners: PharmaStem … [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
25 Jan 2008, 1:00 am
: (IP ThinkTank),IBM patents and defensive publishing: (Securing Innovation),Stockholm Network paper on developing nations and pharmaceutical patents: (IPcentral Weblog),Good and bad news for the IP industry if recession does bite: (IAM),Business Software Alliance: Piracy economic impact is tens of billions of dollars: (Ars Technica),IP portfolio costs - when less is more: (IP ThinkTank),IP protection: Competitive market default: (The Fire… [read post]
11 Jan 2008, 9:00 am
China is liable for copyright infringement because it provided search and linking services that directed users to sound recordings Yahoo! [read post]
23 Dec 2007, 8:00 pm
: (IPKat),Amazon gift ordering patent revoked by the EPO: (OUT-LAW), (IP Law360)Legal protection for databases: case report on dispute between the British Horseracing Board and William Hill: (OUT-LAW),Court of First Instance rejects Enercon's appeal to register a football-shaped wind turbine as a Community trade mark: (Mondaq.com),More on registrability of Tarzan's yell as a trade mark at OHIM: (OUT-LAW), (more from OUT-LAW),Gateway Inc. cannot… [read post]
14 Dec 2007, 1:00 am
Gore & Associates Inc. held to have willfully infringed rival C.R. [read post]
15 Mar 2007, 2:12 am by Dariusz Czuchaj
Other pharmaceutical companies that have filed WIPO cases in the past include Pharmacia & Upjohn (in relation to Rogaine), American Home Products, McNeil Consumer Brands (Tylenol), Pfizer (Viagra), Merck, Sanofi-Aventis (Ambien), CVS Pharmacy, Lilly ICOS, Valeant, and Bayer. [read post]